ABSTRACT
Preservation of a donor heart for transplantation is limited to 6-8 hours. Based on our demonstration of 12 hour perfusion with plasma cross circulation, this study aimed to evaluate ex vivo heart perfusion (EVHP) for up to 72 hours using cross plasma circulation (XC-plasma) from a live, awake paracorporeal sheep (PCS). Six ovine hearts were perfused for 72 hours using plasma cross circulation at a rate of 1 L/min with a live, awake PCS. Controls were seven perfused hearts without cross circulation. Experiments were electively ended at 72 hours, and epinephrine (0.1 mg) was delivered to demonstrate hormonal responsiveness. All controls failed at 6-10 hours. All six hearts perfused for 72 hours maintained normal heart function, metabolism, and responsiveness to epinephrine. Blood gases, electrolytes, and lactate levels were normal and stable throughout the study. All hearts appeared suitable for transplantation. We have demonstrated successful normothermic EVHP for 72 hours.
Subject(s)
Cross Circulation/methods , Heart Transplantation , Organ Preservation/methods , Perfusion/methods , Animals , Extracorporeal Circulation/methods , SheepABSTRACT
The number of available donor organs limits lung transplantation, the only lifesaving therapy for the increasing population of patients with end-stage lung disease. A prevalent etiology of injury that renders lungs unacceptable for transplantation is gastric aspiration, a deleterious insult to the pulmonary epithelium. Currently, severely damaged donor lungs cannot be salvaged with existing devices or methods. Here we report the regeneration of severely damaged lungs repaired to meet transplantation criteria by utilizing an interventional cross-circulation platform in a clinically relevant swine model of gastric aspiration injury. Enabled by cross-circulation with a living swine, prolonged extracorporeal support of damaged lungs results in significant improvements in lung function, cellular regeneration, and the development of diagnostic tools for non-invasive organ evaluation and repair. We therefore propose that the use of an interventional cross-circulation platform could enable recovery of otherwise unsalvageable lungs and thus expand the donor organ pool.
Subject(s)
Cross Circulation/instrumentation , Lung Transplantation , Lung/physiology , Organ Preservation/instrumentation , Perfusion/instrumentation , Animals , Cross Circulation/methods , Disease Models, Animal , Humans , Organ Preservation/methods , Perfusion/methods , Pulmonary Disease, Chronic Obstructive/surgery , Regeneration , Respiratory Aspiration of Gastric Contents/complications , Swine , Swine, Miniature , Tissue Donors , Tissue and Organ Harvesting/methodsABSTRACT
We established an exogenous biological renal support model through the generation of parabiotic mice. At 72 hours after ischemia reperfusion injury (IRI), the aged mice that received exogenous biological renal support showed significantly higher levels of renal cell proliferation and dedifferentiation, lower levels of renal tubular injury, improved renal function, and a lower mortality than those that did not receive exogenous biological renal support. Using the Quantibody Mouse Cytokine Antibody Array, we found that aged IRI mice that received exogenous biological renal support had an up-regulation of multiple inflammatory related cytokines compared to the group that did not receive exogenous biological renal support. We suggest that the exogenous biological renal support might promote renal tubular epithelial cell proliferation and dedifferentiation and improve the prognosis of aged IRI mice. Exogenous biological renal support may play an important role in the amelioration of renal IRI by regulating the expression of multiple cytokines.
Subject(s)
Acute Kidney Injury/therapy , Kidney/pathology , Parabiosis/methods , Reperfusion Injury/therapy , Acute Kidney Injury/pathology , Acute Kidney Injury/physiopathology , Aging/pathology , Animals , Blood Urea Nitrogen , Cell Dedifferentiation , Cell Proliferation , Creatinine/blood , Cross Circulation/methods , Cytokines/blood , Disease Models, Animal , Kidney/physiopathology , Kidney Tubules/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Prognosis , Reperfusion Injury/pathology , Reperfusion Injury/physiopathologyABSTRACT
The Emax-Pressure-Volume Area (PVA)-VO2 framework proposed by Dr. Suga for canine hearts has dramatically advanced the field of cardiac mechanical work and energetics, i.e., mechanoenergetics. He and his collaborators investigated mechanoenergetics in the left ventricle (LV) of excised, cross-circulated canine heart preparations. We instituted the excised cross-circulated rat whole heart preparations and found a curvilinear end-systolic pressure-volume relation (ESPVR) in the rat LV, in contrast to the linear ESPVR in canine, rabbit, and human LVs. Although Emax, the slope of the linear ESPVR, could be used as an index of LV contractility, it was not applicable for evaluating LV contractility in the rat LV. Thus, we proposed a new index of contractility, equivalent Emax (eEmax) in the rat LV. We also found a linear VO2-PVA relationship in the rat LV. Here, we introduce the methods for the preparation of excised, cross-circulated rat whole hearts and the eEmax-PVA-VO2 framework in the rat LV. Using this method, we can obtain accurate LV volume and myocardial O2 consumption in real time for estimating cardiac mechanoenergetics, which is very challenging in in vivo experiments.
Subject(s)
Cross Circulation/methods , Heart/physiology , Ventricular Function , Animals , Biomechanical Phenomena , Blood Pressure , Cross Circulation/instrumentation , Dogs , Electrocardiography , Energy Metabolism , Equipment Design , Humans , Myocardial Contraction , Oxygen Consumption , Perfusion/instrumentation , Perfusion/methods , Rabbits , Rats, WistarABSTRACT
AIMS: A successful cephalosomatic anastomosis ("head transplant") requires, among others, the ability to control long-term immune rejection and avoidance of ischemic events during the head transference phase. We developed a bicephalic model of head transplantation to study these aspects. METHODS AND RESULTS: The thoracic aorta and superior vena cava of a donor rat were anastomosed with the carotid artery and extracorporeal veins of a recipient rat by vascular grafts. Before thoracotomy in the donor rat, the axillary artery and vein of the donor were connected to the carotid and the extracranial vein of the third rat through a silicone tube. The silicone tube was passed through a peristaltic pump to ensure donor brain tissue blood supply. There is no ischemia reperfusion injury in donor brain tissue analyzed by electroencephalogram. Postoperative donor has pain reflex and corneal reflex. CONCLUSIONS: Peristaltic pump application can guarantee the blood supply of donor brain tissue per unit time, while the application of temperature change device to the silicone tube can protect the brain tissue hypothermia, postoperative experimental data show that there is no brain tissue ischemia during the whole operation. The application of vascular grafting can also provide the possibility of long-term survival of the model.
Subject(s)
Cross Circulation/methods , Head , Transplantation/methods , Animals , Electrocardiography , Electroencephalography , Head/blood supply , Head/surgery , Male , Models, Animal , Oxygen/blood , Rats , Rats, Wistar , Transplantation, HomologousABSTRACT
IMPORTANCE: Alzheimer disease (AD) pathology starts long before clinical symptoms manifest, and there is no therapy to treat, delay, or prevent the disease. A shared blood circulation between 2 mice (aka parabiosis) or repeated injections of young blood plasma (plasma from 2- to 3-month-old mice) into old mice has revealed benefits of young plasma on synaptic function and behavior. However, to our knowledge, the potential benefit of young blood has not been tested in preclinical models of neurodegeneration or AD. OBJECTIVES: To determine whether young blood plasma ameliorates pathology and cognition in a mouse model for AD and could be a possible future treatment for the disease. DESIGN, SETTING, AND PARTICIPANTS: In this preclinical study, mice that harbor a human mutant APP gene, which causes familial AD, were aged to develop AD-like disease including accumulation of amyloid plaques, loss of synaptic and neuronal proteins, and behavioral deficits. The initial parabiosis studies were done in 2010, and the final studies were conducted in 2014. Alzheimer disease model mice were then treated either by surgically connecting them with a young healthy mouse, thus providing a shared blood circulation through parabiosis, or through repeated injections of plasma from young mice. MAIN OUTCOMES AND MEASURES: Neuropathological parameters and changes in hippocampal gene expression in response to the treatment were assessed. In addition, cognition was tested in AD model mice intravenously injected with young blood plasma. RESULTS: Aged mutant amyloid precursor protein mice with established disease showed a near complete restoration in levels of synaptic and neuronal proteins after exposure to young blood in parabiosis (synaptophysin P = .02; calbindin P = .02) or following intravenous plasma administration (synaptophysin P < .001; calbindin P = .14). Amyloid plaques were not affected, but the beneficial effects in neurons in the hippocampus were accompanied by a reversal of abnormal extracellular receptor kinase signaling (P = .05), a kinase implicated in AD. Moreover, young plasma administration was associated with improved working memory (P = .01) and associative memory (P = .02) in amyloid precursor protein mice. CONCLUSIONS AND RELEVANCE: Factors in young blood have the potential to ameliorate disease in a model of AD.
Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/therapy , Blood Component Transfusion/methods , Cross Circulation/methods , Hippocampus/metabolism , Age Factors , Amyloid beta-Protein Precursor , Animals , Disease Models, Animal , Mice , Mice, Inbred C57BL , Mice, TransgenicABSTRACT
This study provides clear evidence that the factor inducing tolerance to ischemia is transmitted via the circulating blood. By using the remote ischemia and the cross-circulation model, the tolerance to ischemia was transmitted from donor to recipient. For this study, the following experimental groups were designed: I, sham control group; II, group of tolerant hindlimb tourniquet-treated rats; III, positive control group; IV, control for cross-circulation influence; preconditioned animals: V, tolerant animals subjected to middle cerebral artery occlusion (MCAO); VI, tolerant animals cross-circulated with SHC, followed by MCAO; VII, SHC animals cross-circulated with tolerant animals and subsequently subjected to MCAO; VIII, tolerant animals cross-circulated with ischemic rats, followed by MCAO; IX, SHC animals cross-circulated with ischemic animals and subjected to MCAO; postconditioned animals: X, ischemic animals treated with a remote limb tourniquet; XI, ischemic animals cross-circulated with SHC control rats; and XII, ischemic animals cross-circulated with tolerant rats. Results confirmed that remote ischemia induced reduction of infarct volume in the preconditioned (V, 60%) as well as in the postconditioned group (X, 52%). Significant diminution was also observed in group XII (56.6%). In the preconditioned group, decreased infarct volume was detected in groups VI and VII (about 65%) and in group IX (about 50%). The greatest infarct reduction (84%) was induced by the presence of ischemic blood in a tolerant rat before ischemia induction. In summary, the factor inducing tolerance to ischemia is generated by remote ischemia and by ischemia itself; from the site of origin to the rest of the body, it is transported by the systemic blood circulation and can be transferred from animal to animal. The effect of conditioning with two different ischemic events (brain and hindlimb ischemia) led to a cumulative, stronger tolerance response.
Subject(s)
Brain Ischemia/blood , Brain Ischemia/prevention & control , Cross Circulation/methods , Ischemic Preconditioning/methods , Animals , Brain Ischemia/physiopathology , Cerebrovascular Circulation/physiology , Rats , Rats, WistarABSTRACT
OBJECTIVE: Although tachycardia is well known to increase cardiac oxygen consumption (Vo2) per min, the relationship between Vo2 for excitation-contraction (E-C) coupling per beat and heart rate change over its full working range still remains controversial. METHODS: To elucidate this relationship, we varied heart rate over a reasonably wide range (60-180 beat/min) and studied the relationship between left ventricular (LV) Emax (load-independent contractility index), PVA (pressure-volume area)-independent Vo2, and basal metabolic Vo2 in nine excised, cross-circulated canine hearts. RESULTS: PVA-independent Vo2 per min significantly increased linearly with increasing heart rate while Emax remained unchanged. Basal metabolic Vo2 per min was measured under KCl arrest. E-C coupling Vo2 per min obtained by subtracting the constant basal metabolic Vo2 from the PVA-independent Vo2 also significantly increased linearly with increasing heart rate. However, PVA-independent Vo2 per beat significantly decreased with increasing heart rate. In contrast, E-C coupling Vo2 per beat, as well as that normalized to Emax, slightly but significantly increased with increasing heart rate. CONCLUSION: The E-C coupling energy for myocardial Ca2+ handling increases with heart rate despite constant contractility in the left ventricle of the excised cross-circulated canine heart.
Subject(s)
Calcium/metabolism , Cross Circulation/methods , Energy Metabolism/physiology , Heart Rate/physiology , Myocardium/metabolism , Animals , Dogs , In Vitro Techniques , Myocardial Contraction/physiology , Oxygen Consumption , Ventricular Function/physiologyABSTRACT
INTRODUCTION: The aim of this study was to analyze the contribution of nonresident progenitor/stem cells and hematopoietic cells to reparative dentinogenesis. METHODS: Parabiosis was established between C57BL/6-TgN(ACTbEGFP)10sb/J transgenic mice (GFP+) and C57BL/6 wild-type mice (GFP-) to ensure blood cross-circulation between animals. Reparative dentinogenesis was stimulated by pulp exposures and capping on the first maxillary molar in the GFP- mice. Histologic sections of injured molars from GFP- mice were analyzed by epifluorescence microscopy to examine the contributions of GFP+ cells (nonresident progenitor cells and hematopoietic cells originating from GFP+ mice) to reparative dentinogenesis. RESULTS: GFP+ cells were detected in close association with reparative dentin formed at the site of pulp exposure in the maxillary first molars of the GFP- mice. CONCLUSIONS: The present study suggests the participation of the nonresident progenitor cells and hematopoietic cells in reparative dentinogenesis.
Subject(s)
Dentinogenesis/physiology , Hematopoietic Stem Cells/physiology , Parabiosis/methods , Stem Cells/physiology , Acid Phosphatase/analysis , Aluminum Compounds/therapeutic use , Animals , Biomarkers/analysis , Calcium Compounds/therapeutic use , Composite Resins/chemistry , Cross Circulation/methods , Dental Materials/chemistry , Dental Pulp Capping/methods , Dental Pulp Exposure/pathology , Dental Pulp Exposure/therapy , Dentin, Secondary/physiology , Drug Combinations , Flow Cytometry , Fluorescent Dyes , Green Fluorescent Proteins , Isoenzymes/analysis , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Fluorescence , Models, Animal , Molar/pathology , Molar/physiopathology , Odontoblasts/pathology , Oxides/therapeutic use , Pulp Capping and Pulpectomy Agents/therapeutic use , Resin Cements/chemistry , Silicates/therapeutic use , Silicon Dioxide/chemistry , Tartrate-Resistant Acid Phosphatase , Zirconium/chemistryABSTRACT
Between March 26, 1954 and July 19, 1955, C. Walton Lillehei and colleagues operated upon 45 infants and children with previously uncorrectable cardiac anomalies using cross-circulation with a human donor. Late follow-up was obtained in all of the 28 patients discharged after the operation. All of the 20 currently living patients were personally interviewed with regard to their cardiac status. Eight early survivors have died. Three died after repair of a residual cardiac anomaly. Another died 4 months postoperatively from heart failure. The other 4 died 13 to 47 years later: 2 of unknown causes, 1 of pneumonia, and 1 was an accident. Eleven late cardiac operations were performed. Seven were done to correct a residual anomaly. More than 40 years later, 2 patients underwent procedures to correct tricuspid regurgitation. One had a mitral valve procedure, and another underwent coronary artery bypass grafting. Of the current 20 survivors, none is limited from cardiac causes. Considering that these 45 patients represent "the dawn of open-heart surgery," the long-term results are quite remarkable.
Subject(s)
Cross Circulation/history , Cross Circulation/methods , Extracorporeal Circulation/history , Extracorporeal Circulation/methods , Heart Defects, Congenital/history , Heart Defects, Congenital/surgery , Postoperative Complications/etiology , Survivors , Adolescent , Adult , Cause of Death , Child , Child, Preschool , Follow-Up Studies , Heart Defects, Congenital/mortality , History, 20th Century , History, 21st Century , Hospital Mortality , Humans , Infant , Infant, Newborn , Male , Middle Aged , Minnesota , Postoperative Complications/mortality , Postoperative Complications/surgery , Reoperation , Retrospective Studies , Survival Analysis , Young AdultABSTRACT
Si bien 1953 fue el año del descubrimiento del ADN y de la conquista del Monte Everest, también lo fue de un gran invento tecnológico: la máquina corazón-pulmón, la que ofreció un tratamiento, y en muchos casos cura, a la mayoría de las enfermedades cardiovasculares. En efecto, el 6 de mayo de 1953 John Gibbon logró coronar con el éxito el trabajo de toda su vida al cerrar por primera vez una comunicación interauricular en una joven mujer utilizando una máquina corazón-pulmón de su invención. Sin embargo, previamente la cirugía exploró otros caminos para operar el corazón, como la hipotermia, la que consistía en bajar la temperatura del paciente introduciéndolo en una tina de agua fría para luego efectuar la corrección quirúrgica de una malformación del corazón, en el menor tiempo posible. Por otra parte, luego de su primer éxito, los 4 pacientes siguientes de Gibbon fallecieron, por lo que este abandonó todo intento ulterior, lo que fue seguido por un pesimismo generalizado sobre la circulación extracorpórea. Este fue revertido un año más tarde por Walton Lillehei con la introducción de la "circulación cruzada controlada" en la que un paciente, habitualmente un niño, era conectado a un "donante", habitualmente el padre o la madre, cuyo corazón y pulmón servían como un oxigenador para así efectuar la cirugía a corazón abierto del paciente. Finalmente, es el mismo Lillehei, quien un año más tarde introduce el oxigenador de burbujas, simple y de bajo costo, que abrió las puertas de la cirugía a corazón abierto a todos los cirujanos del mundo. Por esto, para muchos, Walton Lillehei es considerado el "Padre de la Cirugía a Corazón Abierto". Lillehei visitó Chile en 1963 y luego de operar en los pabellones del Hospital Clínico de la Universidad Católica fue nombrado Miembro Honorario de la Facultad de Medicina de dicha Universidad. Previamente, en 1957, Helmuth Jaeger había efectuado el primer cierre quirúrgico exitoso de una comunicación interauricular con circul...
Subject(s)
Humans , Cross Circulation/methods , Extracorporeal Circulation/methods , Thoracic Surgery/instrumentation , Hypothermia, Induced/methods , Heart-Lung Machine/history , OxygenatorsABSTRACT
INTRODUCTION: The use of bioartificial liver devices requires. A sufficient liver cell mass to provide adequate metabolic support, reduction of xenogeneic immune reactions, and avoidance of viral transmission. We have developed a plasmapheresis system using a semipermeable membrane combined with canine whole liver perfusion (PMCWLP). In this study, we investigated the efficacy of our system in a porcine fulminant hepatic failure (FHF) model. METHODS: The porcine FHF model was established by intraportal administration of alpha-amanitin (0.1 mg/kg) and lipopolysaccharide (1 microg/kg). Nine hours after drug injection, xenogenic perfusion treatment was performed twice within 6 hours (n = 5). As the plasmapheresis device, we used a hollow-fiber module with cellulose diacetate porous fibers (pore size, 0.05 microm, surface area, 2 m2). The canine whole liver was perfused with modified Krebs solution, which is commonly used in many laboratories, containing albumin (2 g/dL) and glucose (300 mg/dL). Control pigs (n = 10), had the circuit not connected to the whole canine liver. RESULTS: The survival of FHF pigs was significantly increased by the treatment (58.9 +/- 21.8 hour) compared with the controls (22.3 +/- 8.1 hour). Mean blood ammonia levels and intracranial pressure during treatment were significantly lower compared with control groups. CONCLUSION: Treatment of FHF pigs with the system significantly increased survival time, suggesting that this method may have applications as a clinical liver assist device.
Subject(s)
Cross Circulation/methods , Liver Failure, Acute/therapy , Plasmapheresis/methods , Transplantation, Heterologous/physiology , Animals , Aspartate Aminotransferases/blood , Blood Pressure , Cross Circulation/instrumentation , Disease Models, Animal , Dogs , Extracorporeal Circulation/methods , Factor VII/metabolism , Female , Liver Failure, Acute/physiopathology , Membranes, Artificial , Plasmapheresis/instrumentation , Serum Albumin/analysis , SwineABSTRACT
INTRODUCTION: Many types of isolated hepatocytes-based bioartificial liver have been developed. However, to maintain hepatocyte-specific functions for a long period is still a significant challenge. The possibilities of rejection or viral transmission still remain as untackled obstacles. We developed a cross-circulation system, using a semipermeable membrane combined with whole liver perfusion. Detoxifying functions of the extracorporeal porcine liver and molecular movements across the membrane were evaluated in vitro. METHODS: The hollow-fiber module has a molecular cutoff of 100 kD. A spiked solution containing 500 mL low molecular dextran solution spiked with 12 mg ammonium chloride, 500 mg D-galactose, and 300 mg lidocaine, which mimicked a patient, was recirculated through the inner fiber space. The extracorporeal liver perfusion circuit consisted of an extra-fiber spaces. A reservoir containing 1000 mL healthy pig plasma, a membrane oxygenator, and a porcine whole liver. Both circuits circulated in the opposite direction for 6 hours. RESULT: In 6 hours, 47.3% +/- 10.2% of ammonia, 89.5% +/- 1.7% of D-galactose, and 95.5% +/- 1.0% of lidocaine were eliminated from the circuits; 66.5 +/- 11.1 mg of urea were produced at the same time. Oxygen consumption was maintained between 0.248 and 0.259 mL/100 g liver/min for 6 hours. Movement of IgM was completely blocked by the 100-kD membrane, whereas albumin was freely transferred from the reservoir to the intrafiber space. CONCLUSION: The perfusion experiments showed the possibility of using a whole liver with oxygenated plasma perfusion in a bioartificial liver system in vitro.
Subject(s)
Cross Circulation/methods , Liver, Artificial , Liver/physiology , Animals , Extracorporeal Circulation/methods , Immunoglobulin M/blood , Membranes, Artificial , Oxygen Consumption , Permeability , Swine , Urea/bloodABSTRACT
In the present study we standardized an experimental model of parabiotic circulation of isolated pig heart. The isolated heart was perfused with arterial blood from a second animal as support and submitted to regional ischemia for 30 min, followed by total ischemia for 90 min and reperfusion for 90 min. Parameters for measurement of ventricular performance using different indices measured directly or indirectly from intraventricular pressure were defined as: maximum peak pressure, final diastolic pressure, pressure developed, first derivative of maximum pressure (dP/dt max), first derivative of minimum pressure (dP/dt min), systolic stress of the left ventricle (sigmas), and maximum elastance of the left ventricle. Isolated hearts subjected to regional and global ischemia presented significant worsening of all measured parameters. Less discriminative parameters were dP/dt max and dP/dt min. Elastance was the most sensitive parameter during the reperfusion period, demonstrating an early loss of ventricular function during reperfusion. The model proved to be stable and reproducible and permitted the study of several variables in the isolated heart, such as ischemia and reperfusion phenomena, the effects of different drugs, surgical interventions, etc. The model introduces an advantage over the classical models which use crystalloid solutions as perfusate, because parabiotic circulation mimics heart surgery with extracorporeal circulation.
Subject(s)
Cross Circulation/methods , Myocardial Reperfusion/methods , Ventricular Function, Left/physiology , Analysis of Variance , Animals , Blood Pressure/physiology , Heart Rate/physiology , Myocardial Reperfusion/standards , SwineABSTRACT
Xenogeneic extracorporeal liver perfusion (ECLP) has the potential to become an important tool in the management of patients with severe liver failure. We previously showed that xenogeneic pig liver perfusion may be prolonged for up to 9 hours by the administration of prostaglandin E(1) (PGE(1)). In this study, we used a canine model of acute liver failure to evaluate the effects of PGE(1) on the efficacy of ECLP as a liver-assist device. Liver failure was surgically induced in 12 beagle dogs, with a control group (group 1, n = 4) not connected to the ECLP circuit. Direct cross-circulation between the dogs and the ECLP circuit using a pig liver was performed without (group 2, n = 4) or with (group 3, n = 4) continuous administration of PGE(1) through the portal vein of the pig liver. The duration of cross-circulation in group 3 (9.4 +/- 1.2 hours) was significantly longer than in group 2 (4.3 +/- 1.0 hours). In addition, elevation of blood ammonia, total bile acid, and hyaluronic acid levels was less marked in group 3 compared with the other 2 groups. The ratio of branched-chain amino acids to aromatic amino acids was also improved in group 3. The mean survival time in group 3 (26.6 +/- 0.4 hours) was significantly longer than in group 1 (15.5 +/- 1.3 hours) or group 2 (17.1 +/- 2.9 hours). Continuous administration of PGE(1) to xenogeneic ECLP resulted in a significant improvement in both liver function and survival time of dogs with surgically induced liver failure.
Subject(s)
Alprostadil/pharmacology , Cross Circulation/methods , Extracorporeal Circulation/methods , Liver Failure, Acute/therapy , Alprostadil/administration & dosage , Amino Acids/blood , Amino Acids, Branched-Chain/blood , Ammonia/blood , Animals , Bile/physiology , Bile Acids and Salts/blood , Disease Models, Animal , Dogs , Hyaluronic Acid/blood , Liver Circulation , Liver Failure, Acute/pathology , Liver Failure, Acute/physiopathology , Perfusion , Swine , Time FactorsABSTRACT
Antecedentes: La falla hepática es una causa importante de morbilidad y mortalidad en Unidades de Terapia Intensiva. Las terapias convencionales no son lo suficientemente efectivas. El trasplante hepático es el tratamiento definitivo para esta entidad, pero debido a la falta de donantes se hacía necesario desarrollar una "terapia puente" o de sostén de la vida hasta que aquél se realizara. La xenohemodiafiltración hepática extracorpórea pretende ser el soporte transitorio de un paciente con falla hepática fulminante. Objetivo: Presentamos el primer caso de xenohemodiafiltración hepática extracorpórea. Lugar de aplicación: Hospital Italiano de Buenos Aires. Diseño: Descripción del primer caso clínico de xenohemodialfiltración. Población: Mujer de 42 años portadora de falla hepática fulminante, con grave alteración de la coagulación, déficit de factor V y severa hipertensión intracraneana. Método: El sistema consiste en una circulación cruzada entre un hígado porcino y un paciente con falla hepática fulminante a través de una membrana de poliacrilonitril. Resultados: El procedimiento duró 5 horas y alcanzó mejoras hemodinámicas, bioquímicas y metabólicas. La presión intracraneana disminuyó de 34 a 5 cm H2O, el amoníaco sérico cayó de 673 a 370 ng/dl, ácido láctico de 11 a 5.3 mmol/L y la bilirrubina de 7.4 a 2.5 mg/dl. Los valores hemodinámicos se mantuvieron estables durante el procedimiento. La paciente pudo recibir el trasplante y continúa viva 11 meses después. Conclusiones: La xenohemodiafiltración hepática extracorpórea es un método clínico experimental que puede constituir una terapia clínica alternativa para soporte de pacientes con falla hepática fulminante hasta que se obtenga un órgano apto para trasplante. (AU)
Subject(s)
Humans , Female , Adult , Hepatic Insufficiency/mortality , Hepatic Insufficiency/therapy , Hepatic Insufficiency/physiopathology , Hepatic Insufficiency/etiology , Hepatic Insufficiency/diagnostic imaging , Hemodiafiltration/methods , Liver Transplantation , Life Support Care/methods , Anesthesia, Local , Blood Coagulation Disorders/complications , Factor V Deficiency , Intracranial Hypertension , Cross Circulation/methods , Perfusion , Third-Party Consent , Hemodynamics , Complementary Therapies , Clinical EvolutionABSTRACT
Antecedentes: La falla hepática es una causa importante de morbilidad y mortalidad en Unidades de Terapia Intensiva. Las terapias convencionales no son lo suficientemente efectivas. El trasplante hepático es el tratamiento definitivo para esta entidad, pero debido a la falta de donantes se hacía necesario desarrollar una "terapia puente" o de sostén de la vida hasta que aquél se realizara. La xenohemodiafiltración hepática extracorpórea pretende ser el soporte transitorio de un paciente con falla hepática fulminante. Objetivo: Presentamos el primer caso de xenohemodiafiltración hepática extracorpórea. Lugar de aplicación: Hospital Italiano de Buenos Aires. Diseño: Descripción del primer caso clínico de xenohemodialfiltración. Población: Mujer de 42 años portadora de falla hepática fulminante, con grave alteración de la coagulación, déficit de factor V y severa hipertensión intracraneana. Método: El sistema consiste en una circulación cruzada entre un hígado porcino y un paciente con falla hepática fulminante a través de una membrana de poliacrilonitril. Resultados: El procedimiento duró 5 horas y alcanzó mejoras hemodinámicas, bioquímicas y metabólicas. La presión intracraneana disminuyó de 34 a 5 cm H2O, el amoníaco sérico cayó de 673 a 370 ng/dl, ácido láctico de 11 a 5.3 mmol/L y la bilirrubina de 7.4 a 2.5 mg/dl. Los valores hemodinámicos se mantuvieron estables durante el procedimiento. La paciente pudo recibir el trasplante y continúa viva 11 meses después. Conclusiones: La xenohemodiafiltración hepática extracorpórea es un método clínico experimental que puede constituir una terapia clínica alternativa para soporte de pacientes con falla hepática fulminante hasta que se obtenga un órgano apto para trasplante.
Subject(s)
Humans , Female , Adult , Anesthesia, Local , Blood Coagulation Disorders/complications , Cross Circulation/methods , Life Support Care/methods , Factor V Deficiency , Hemodiafiltration/methods , Hepatic Insufficiency/etiology , Hepatic Insufficiency/physiopathology , Hepatic Insufficiency/mortality , Hepatic Insufficiency/therapy , Hepatic Insufficiency , Intracranial Hypertension , Perfusion , Liver Transplantation , Clinical Evolution , Complementary Therapies , Hemodynamics , Third-Party ConsentABSTRACT
The present paper focuses on the immunological and morphological aspects of extracorporal joining up of donor porcine spleen in the treatment of psoriasis. It has been ascertained that extracorporal joining up of donor porcine in the treatment of psoriasis makes for normalization of bodily immunologic reactivity leading to regression of psoriatic eruptions.
Subject(s)
Cross Circulation/methods , Hemoperfusion/methods , Psoriasis/therapy , Spleen , Animals , Humans , Neutrophils/immunology , Psoriasis/immunology , Spleen/pathology , Swine , Time FactorsABSTRACT
A comprehensive clinical-and-immunological evaluation was done of efficiency of treatment of patients with severe forms of bronchial asthma (BA) by hemosorption through donor porcine spleen, xenosorption (XS), in 63 patients. XS was found out to have a marked positive clinical effect manifested by a considerable decrease of frequency of asphyxiation bouts and amounts of inhalation broncholytics being taken within the first 24 hours after the procedure. By day 14 from the start of XS we succeeded in lowering the systemic corticosteroids maintenance dose on the average 2.5 times as little. Positive clinical dynamics correlated with positive immunologic changes which revealed themselves in normalization of numbers as well as functional activity of T-cells, rise in T-helpers, normalization of content of serum immunoglobulins A, M and G, with the parameters characterizing the system of phagocytosis approaching the norm, the processes of autoimmunization getting more attenuated.
Subject(s)
Asthma/therapy , Cross Circulation/methods , Sorption Detoxification/methods , Spleen , Acute Disease , Adult , Animals , Antibody Formation , Asthma/immunology , Female , Humans , Immunity, Cellular , Male , Remission Induction , SwineABSTRACT
A haemodynamically significant ventricular septal defect was diagnosed in a 3-month-old male Cavalier King Charles Spaniel. A median sternotomy was performed and the 6.5 kg dog placed on cardiopulmonary bypass using pump-assisted cross-circulation. A 10 mm diameter peri-membranous ventricular septal defect was closed using a continuous suture of 4-0 polypropylene, via a 2.5 cm incision in the right ventricular outflow tract. The duration of cardiopulmonary bypass was 90 minutes. Complications in the immediate postoperative period were mild and easily managed.